Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
S-nitrosylation: integrator of cardiovascular performance and oxygen delivery
Saptarsi M. Haldar, Jonathan S. Stamler
Saptarsi M. Haldar, Jonathan S. Stamler
Published January 2, 2013
Citation Information: J Clin Invest. 2013;123(1):101-110. https://doi.org/10.1172/JCI62854.
View: Text | PDF
Review Series

S-nitrosylation: integrator of cardiovascular performance and oxygen delivery

  • Text
  • PDF
Abstract

Delivery of oxygen to tissues is the primary function of the cardiovascular system. NO, a gasotransmitter that signals predominantly through protein S-nitrosylation to form S-nitrosothiols (SNOs) in target proteins, operates coordinately with oxygen in mammalian cellular systems. From this perspective, SNO-based signaling may have evolved as a major transducer of the cellular oxygen-sensing machinery that underlies global cardiovascular function. Here we review mechanisms that regulate S-nitrosylation in the context of its essential role in “systems-level” control of oxygen sensing, delivery, and utilization in the cardiovascular system, and we highlight examples of aberrant S-nitrosylation that may lead to altered oxygen homeostasis in cardiovascular diseases. Thus, through a bird’s-eye view of S-nitrosylation in the cardiovascular system, we provide a conceptual framework that may be broadly applicable to the functioning of other cellular systems and physiological processes and that illuminates new therapeutic promise in cardiovascular medicine.

Authors

Saptarsi M. Haldar, Jonathan S. Stamler

×

Figure 2

S-nitrosylation regulates cardiomyocyte signaling at critical oxygen-responsive nodal points.

Options: View larger image (or click on image) Download as PowerPoint

S-nitrosylation regulates cardiomyocyte signaling at critical oxygen-re...
The central roles are highlighted for the denitrosylase GSNOR in physiologic control of β2-AR signaling, SR calcium release, HIF-1α responses, and mitochondrial function. S-nitrosylation reactions that have been proven by genetic criteria to occur through the intermediacy of GSNO include those targeting GRK2, RYR2, and HIF-1α. Ligand-dependent S-nitrosylation of GRK2, β-arrestin2, and dynamin is eNOS dependent. eNOS is complexed with GRK2, β-arrestin2, and dynamin, as depicted. Coordinate titration of S-nitrosylation (envisioned via receptor-coupled activity of transnitrosylases and denitrosylases) across multiple steps in these pathways determine net signaling responses. The effects of GSNOR (from observations in GSNOR–/– mice) manifest as increases in cardiac output under basal conditions, a persistent state of systemic vasodilation, and protection from ischemic insult, establishing a central role for GSNO in cardiovascular hemodynamics and oxygen delivery. Effects of GSNOR on mitochondrial targets are inferred from studies using GSNO. HRE, hypoxia response element.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts